Pharmaceutical giant AstraZeneca is to axe 300 jobs from its UK marketing division, following a review of its activities.
It follows a decision taken in February to cut 700 manufacturing jobs over the next three years at its Macclesfield plant.
The core purpose of the UK Marketing Company is to create demand for and sell AstraZeneca products. It is responsible for all customer interface in the UK which includes an extensive clinical research programme, as well as marketing, sales and customer services.
AstraZeneca said the affected jobs from its UK Marketing Company will be cut before the end of the financial year. The department is responsible for all UK customer interface and includes a clinical research programme, and marketing, sales and customer services.
Chris Brinsmead, AstraZeneca UK company president, said: “We have recently re-aligned our primary care sales organisation and our medical & regulatory affairs teams to match the strategic health authority structure of the NHS.
“We have also introduced new ways of working that will better support the needs of our customers.
“We will, of course, ensure that our people are fully consulted and will do everything we possibly can to reduce the number of people affected,” he added.
